PAVmed Inc.

NASDAQ:PAVM

1.11 (USD) • At close November 8, 2024
Bedrijfsnaam PAVmed Inc.
Symbool PAVM
Munteenheid USD
Prijs 1.11
Beurswaarde 11,551,104
Dividendpercentage 0%
52-weken bereik 0.6 - 4.875
Industrie Medical Devices
Sector Healthcare
CEO Dr. Lishan Aklog M.D.
Website https://www.pavmed.com

An error occurred while fetching data.

Over PAVmed Inc.

PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted

Vergelijkbare Aandelen

Puma Biotechnology, Inc. logo

Puma Biotechnology, Inc.

PBYI

2.88 USD

HOOKIPA Pharma Inc. logo

HOOKIPA Pharma Inc.

HOOK

3.76 USD

Alzamend Neuro, Inc. logo

Alzamend Neuro, Inc.

ALZN

1.49 USD

Adverum Biotechnologies, Inc. logo

Adverum Biotechnologies, Inc.

ADVM

8 USD

Xilio Therapeutics, Inc. logo

Xilio Therapeutics, Inc.

XLO

0.99 USD

LAVA Therapeutics N.V. logo

LAVA Therapeutics N.V.

LVTX

1.85 USD

Cytosorbents Corporation logo

Cytosorbents Corporation

CTSO

0.74 USD

Lucid Diagnostics Inc. logo

Lucid Diagnostics Inc.

LUCD

1.04 USD

Aeglea BioTherapeutics, Inc. logo

Aeglea BioTherapeutics, Inc.

AGLE

12.01 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)